Cystitis, Interstitial clinical trials
The registry lists 236 studies for Cystitis, Interstitial across more than 10 countries. 35 are recruiting or about to start. 202 of them are mainly about Cystitis, Interstitial (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.
Get an email when these change. Save the Cystitis, Interstitial studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
William Beaumont Hospitals (8) · Wake Forest University Health Sciences (8) · Allergan (7) · University of Pennsylvania (7) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (7) · Samsung Medical Center (5) · Walter Reed National Military Medical Center (5) · Buddhist Tzu Chi General Hospital (5)
What is being tested here
Drugs under test in Cystitis, Interstitial studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest, phase 3 first
- May 2027Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome · Phase 3 · David Sheyn
- May 2027The Study is Being Conducted to Find a New Treatment for Patients Suffering From Interstitial Cystitis Without Hunner's Lesions. · Phase 3 · JSC NextGen
- Oct 2027The Study is Being Conducted to Find a New Treatment for Patients Suffering From Interstitial Cystitis With Hunner's Lesions · Phase 3 · JSC NextGen
- Dec 2026Safety and Preliminary Efficacy of Endoscopic Submucosal Injection of Hyaluronic Acid Into the Bladder Wall in Patients With Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) · Sverdlovsk Regional Clinical Hospital No.1
- Dec 2026New Approaches to Nerve Stimulation Therapy for Bladder Pain Syndrome · Walter Reed National Military Medical Center
- Dec 2026Early vs Delayed Intravesical Blad-Care During BCG Therapy · BLAD-HYA Group
- Dec 2026Mirogabalin Plus EBMP for IC/BPS · Beijing Tiantan Hospital
- Dec 2026fMRI for BPS: A Descriptive Study of Findings and Symptoms · RenJi Hospital
- Jan 2027Investigation of PEMF Therapy for Female Patients With IC/BPS · Wake Forest University Health Sciences
- Apr 2027Safety and Efficacy of Aloe Vera in the Management of the Symptoms of Interstitial Cystitis · Wake Forest University Health Sciences
Who these studies take
Of the 25 Cystitis, Interstitial studies recruiting now, 15 (60%) set no upper age limit and 5 (20%) stop at 75 or younger. 2 (8%) take children under 18. 9 (36%) are for women only and 0 (0%) for men only; 5 (20%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 2 (8%) | 2 (8%) |
| 18 | 24 (96%) | 15 (60%) |
| 30 | 25 (100%) | 16 (64%) |
| 40 | 25 (100%) | 16 (64%) |
| 50 | 25 (100%) | 16 (64%) |
| 65 | 25 (100%) | 16 (64%) |
| 75 | 20 (80%) | 14 (56%) |
| 85 | 17 (68%) | 12 (48%) |
Across all 236 studies, recruiting or not: 20% stop at 75 or younger and 13% at 65; 4% take children; 49% are for women only and 0% for men only; 19% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Cystitis, Interstitial studies take
Of 19 phase 2 interventional studies under Cystitis, Interstitial, half reached primary completion within 27 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Phase 2 | 27 mo17–34 · 19 studies | — | — |
| Interventional, no phase | 23 mo16–38 · 39 studies | — | 23 mo16–34 · 35 studies |
| Observational | 21 mo8–69 · 21 studies | — | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 11, 2026.
Stopped1
- Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells for Peyronie's Disease, ED, and Interstitial CystitisTerminatedOct 20, 2026NCT05147779
Newly registered1
Studies
Recruiting first, then most recently updated. Showing 50 of 236. Browse all 236 → or search them.
- Clinical Efficacy of Jing Si Herbal Tea Liquid Packet to Treat Patients With Interstitial Cystitis/Bladder Pain SyndromeEnrolling by invitationNCT07927738Not applicable1 country
- Migraine Medication Effects on Urinary SymptomsEnrolling by invitationNCT062126611 country
- EPPIC: Easing Pelvic Pain Interventions Clinical Research ProgramRecruitingNCT05127616Not applicable1 country
- Investigation of PEMF Therapy for Female Patients With IC/BPSRecruitingNCT05149573Not applicable1 country
- Aerobic Exercise and Connective Tissue Massage in Painful Bladder SyndromeRecruitingNCT07839689Not applicable1 country
- Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder SyndromeRecruitingNCT06096597Phase 2/31 country
- Mirogabalin Plus EBMP for IC/BPSNot yet recruitingNCT07803393Phase 1
- Efficacy and Safety of Pregabalin Combined With Educational and Behavioral Intervention for Bladder Pain Syndrome/Interstitial CystitisNot yet recruitingNCT07752134Phase 1
- Safety and Efficacy of Aloe Vera in the Management of the Symptoms of Interstitial CystitisRecruitingNCT04734106Early Phase 11 country
- Venlafaxine Combined With Education and Behavioral Intervention for Bladder Pain SyndromeNot yet recruitingNCT07698626Phase 1
- Safety and Preliminary Efficacy of Endoscopic Submucosal Injection of Hyaluronic Acid Into the Bladder Wall in Patients With Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)Not yet recruitingNCT07658118Phase 1
- Genetic Study of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)RecruitingNCT004993171 country
- New Approaches to Nerve Stimulation Therapy for Bladder Pain SyndromeRecruitingNCT06204874Not applicable1 country
- Early vs Delayed Intravesical Blad-Care During BCG TherapyRecruitingNCT07495072Not applicable1 country
- The Study is Being Conducted to Find a New Treatment for Patients Suffering From Interstitial Cystitis With Hunner's LesionsRecruitingNCT07459790Phase 2/31 country
- The Study is Being Conducted to Find a New Treatment for Patients Suffering From Interstitial Cystitis Without Hunner's Lesions.RecruitingNCT07391306Phase 2/31 country
- Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS)RecruitingNCT06394830Phase 21 country
- Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPSRecruitingNCT05737121Phase 21 country
- Pain Type and Interstitial Cystitis/Bladder Pain Syndrome TreatmentRecruitingNCT06299683Not applicable1 country
- Acupuncture First for IC/BPSRecruitingNCT06366269Not applicable1 country
- Identifying Genetic Causes of IC/BPSRecruitingNCT003891421 country
- The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial)RecruitingNCT05726786Phase 31 country
- Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMARecruitingNCT057541901 country
- A Novel Medical System for Quantitative Diagnosis and Personalized Precision Botulinum Neurotoxin Injection in Chronic Pelvic Pain ManagementNot yet recruitingNCT05062902Early Phase 11 country
- Intravesical Ozone Therapy for Interstitial Cystitis/Bladder Pain SyndromeNot yet recruitingNCT06863220Not applicable1 country
- Bladder Botox UTI Antibiotic ProphylaxisRecruitingNCT06387329Phase 41 country
- Evaluating the Efficacy and Patient Experience of Catheter-Free Intravesical InstillationRecruitingNCT067192321 country
- Effect of Intradetrusor onabotulinumtoxinA Injection Versus Conservative Management on Female Sexual Function in Patients With Bladder Pain SyndromeRecruitingNCT067291511 country
- EA for BPS: an RCT and Study for Central MechanismRecruitingNCT05279963Not applicable1 country
- Different Injection Site Maps & Intravesical Botulinum ToxinNot yet recruitingNCT06185218Not applicable
- GAG-therapy Efficacy Trial Solution for Bladder Pain Syndrome/ Interstitial Cystitis (GETSBI Study)RecruitingNCT05518864Phase 41 country
- fMRI for BPS: A Descriptive Study of Findings and SymptomsRecruitingNCT062949511 country
- Assessing the Effectiveness and Safety of Interferon Bladder Infusion for the Treatment of Interstitial CystitisNot yet recruitingNCT05912946Phase 2/3
- Perioperative Safety of Bladder Hydrodistension in Patients on Antithrombotic TherapyRecruitingNCT052219441 country
- Peppermint Oil for the Treatment of Interstitial Cystitis / Bladder Pain SyndromeRecruitingNCT04845217Phase 1/21 country
- Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO)Active, not recruitingNCT05696444Not applicable1 country
- Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells for Peyronie's Disease, ED, and Interstitial CystitisTerminatedNCT05147779Phase 11 country
- Learning to THRIVE (L2T) Program PilotCompletedNCT07797010Not applicable1 country
- Evaluation of Hyivy Floora in Managing Interstitial Cystitis/Bladder Pain Syndrome/High-tone Pelvic Floor DysfunctionWithdrawnNCT07038512Not applicable
- Osteopathic Manipulation Therapy in the Treatment of Interstitial CystitisCompletedNCT008731711 country
- Efficacy of Pulsed Electromagnetic Field and Heparin/Bupivacaine InstillationsWithdrawnNCT06013449Not applicable
- Low-dose Naltrexone for Bladder Pain SyndromeTerminatedNCT04450316Phase 21 country
- Phenotyping Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) by Intravesical Contrast Enhanced - Magnetic Resonance Imaging (ICE-MRI) Bladder Permeability AssayCompletedNCT058113771 country
- Bladder Directed vs. Pelvic Floor Therapy in IC/BPSActive, not recruitingNCT02870738Phase 21 country
- A Clinical Study of ONO-1110 in Patients With Hunner Type Interstitial CystitisCompletedNCT06752603Phase 21 country
- Investigation of the Effectiveness of Acupuncture in Patients Diagnosed With Interstitial CystitisCompletedNCT06232200Not applicable1 country
- Motor Cortical Neuromodulation in Women With Interstitial Cystitis/Bladder Pain SyndromeActive, not recruitingNCT04734847Not applicable1 country
- A Multidisciplinary, Multimodal Bundled Care Approach to Chronic Pelvic PainTerminatedNCT05658874Phase 31 country
- Vestibulodynia: Understanding Pathophysiology and Determining Appropriate TreatmentsCompletedNCT03844412Phase 21 country
- Study of V117957 in Interstitial Cystitis/Bladder Pain SyndromeCompletedNCT06285214Phase 11 country